[ORGANIZATION]
Skyrizi
Featured in 4 tracked stories · first seen
Situations
AbbVie immunology pipeline and strategic transition
2 clusters · 4 sources · last updated
Latest: AbbVie completes $10.9 billion acquisition of Apogee Therapeutics
AbbVie is undergoing a strategic transition to mitigate the impact of biosimilar competition on its blockbuster drug, Humira. Following a decline in Humira sales to $6.4 billion in 2025, the company has relied on the gro
Also covered in
-
Skyrizi receives AIFA reimbursement for ulcerative colitis in Italy
[HEALTH] · 8 sources ·